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Background and Objective: Genetic markers associated with disease are often
non-functional and generally tag one or more functional “causative” variants in
linkage disequilibrium. Markers may not show tight linkage to the causative
variants across multiple ethnicities due to evolutionary divergence, and therefore
may not be informative across different population groups. Validated markers
of disease suggest causative variants exist in the gene and, if the causative vari-
ants can be identified, it is reasonable to hypothesize that such variants will be
informative across diverse populations. The aim of this study was to test that
hypothesis using functional Interleukin-1 (IL-1) gene variations across multiple
ethnic populations to replace the non-functional markers originally associated
with chronic adult periodontitis in Caucasians.
Material and Methods: Adult chronic periodontitis cases and controls from four
ethnic groups (Caucasians, African Americans, Hispanics and Asians) were
recruited in the USA, Chile and China. Genotypes of IL1B gene single nucleo-
tide polymorphisms (SNPs), including three functional SNPs (rs16944,
rs1143623, rs4848306) in the promoter and one intronic SNP (rs1143633), were
determined using a single base extension method or TaqMan 50 nuclease assay.
Logistic regression and other statistical analyses were used to examine the asso-
ciation between moderate to severe periodontitis and IL1B gene variations,
including SNPs, haplotypes and composite genotypes. Genotype patterns associ-
ated with disease in the discovery study were then evaluated in independent
validation studies.
Results: Significant associations were identified in the discovery study, consisting
of Caucasians and African Americans, between moderate to severe adult chronic
periodontitis and functional variations in the IL1B gene, including a pattern of
four IL1B SNPs (OR = 1.87, p < 0.0001). The association between the disease
and this IL1B composite genotype pattern was validated in two additional stud-
ies consisting of Hispanics (OR = 1.95, p = 0.04) or Asians (OR = 3.27,
p = 0.01). A meta-analysis of the three populations supported the association
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between the IL-1 genotype pattern and moderate to severe periodontitis (OR
1.95; p < 0.001). Our analysis also demonstrated that IL1B gene variations had
added value to conventional risk factors in predicting chronic periodontitis.
Conclusion: This study validated the influence of IL-1 genetic factors on the
severity of chronic periodontitis in four different ethnicities.
Introduction
Chronic periodontitis in adults is
highly prevalent, affecting 47% in the
USA with 39% having moderate to
severe disease (1). Approximately
8–13% of adults across diverse popu-
lations exhibit severe generalized dis-
ease (1–3). Although bacteria are
essential for the initiation and pro-
gression of chronic periodontitis,
studies in twins indicate that approxi-
mately 50–60% of the variance
observed in clinical disease expression
in adults is genetically determined (4).
The role of specific genetic variants
in chronic periodontitis in Caucasians
has been evaluated and reported for
approximately 37 candidate genes, of
which five have been validated by
meta-analyses. Six additional loci have
been implicated in a genome-wide asso-
ciation study (5). A small number of
candidate gene studies have also been
reported in Asian populations (6–8)
and even fewer in other ethnic groups.
Of all the gene variations studied in
chronic periodontitis, two interleukin-1
IL-1 gene variations (IL1A [–889;
rs1800587] or the concordant IL1A
[+4845; rs17561] and IL1B [+3954;
rs1143634]) have been most consis-
tently associated with severe or progres-
sive chronic periodontitis in Caucasians
with significant associations reported
for 19 of 27 studies and validated in two
meta-analyses (9,10). The same IL-1
variations also have been associated
with higher gingival crevicular fluid lev-
els or monocyte expression of IL-1a
(11) or IL-1b in some but not all studies
(12–15). However, these variants are
infrequent and not informative in
Chinese (16) and Japanese (17) and
have uncertain value in other non-Cau-
casian ethnicities (18,19).
One primary goal of genetic associa-
tion studies is to localize a physical
segment of the genome and identify
functional gene variants that influence
important phenotypic characteristics
of the disease. Functional variants not
only provide a target for disease modi-
fying interventions but also should
reduce the variation in genetic associa-
tion across diverse populations. Based
on evidence validating a role for IL-1
gene variants in chronic periodontitis
in Caucasians, we sought and have
previously reported the characteriza-
tion of gene variations that are func-
tional at the molecular level (20).
These variants include three single
nucleotide polymorphisms (SNPs)
(rs16944, rs1143623 and rs4848306) in
the IL1B promoter region that were
shown to act in haplotype context to
define allele-specific transcriptional dif-
ferences and differences in gingival
crevicular fluid levels of IL-1b and
blood high-sensitivity C-reactive pro-
tein levels (21).
This study sought to determine if
specific patterns of the functional
IL1B SNPs were associated with peri-
odontitis across multiple ethnic popu-
lations. Genotype patterns associated
with disease were initially identified in
a discovery study consisting of two
ethnic groups followed by validation




Discovery population— The subjects
for the discovery phase of this study
were selected from the Atherosclerosis
Risk in Communities (ARIC) study
(22). The ARIC is a prospective study
designed primarily to investigate the
causes of atherosclerosis and its clinical
outcomes. The study enrolled 15,792
subjects by probability sampling
from four communities in the USA.
These included: Forsyth County, NC;
Jackson, MS; Minneapolis, MN; and
Washington County, MD. At the
fourth visit, all eligible and consented
subjects underwent dental examina-
tions (23) and a random subset, includ-
ing 900 Caucasians and 227 African
Americans aged 53–74 years, were
included in the current study for identi-
fying genetic risk for periodontitis
across multiple ethnic populations.
Full mouth periodontal examinations
were performed as described previously
(24). Periodontal parameter data,
including pocket depth, clinical attach-
ment loss and bleeding on probing
(BOP), and detailed medical history
data were collected and reported previ-
ously (23–26).
Validation populations— The valida-
tion samples included both Hispanics
and Asians and were recruited in two
case–control studies. The Hispanic
subjects were recruited in Santiago,
Chile from patients receiving preven-
tive primary care at a public health-
care center (27). The majority of the
Chilean population is an admixture of
European and Amerindian with vary-
ing proportions of the two lineages
depending on socio-economic status.
Full mouth periodontal examinations
were performed to assess periodontal
conditions that included measure-
ments of pocket depth, clinical attach-
ment loss and BOP. In addition,
detailed medical history was obtained
and blood samples were collected for
laboratory analysis. Patients were
excluded if they were younger than
35 years, had systemic diseases that
influence progression of periodontitis
(i.e. diabetes mellitus and rheumatoid
arthritis), or had treatment with anti-
biotics or regular use of non-steroidal
anti-inflammatory drugs in the previ-
ous 6 mo.
The Asian subjects were ethnic Han
Chinese aged 35 years or older who
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were recruited from dental clinics,
schools and factories in Shanghai,
China. All subjects underwent peri-
odontal examinations and completed
a questionnaire on demographic and
general health information. Partial
mouth examinations were performed
according to the Community Peri-
odontal Index of Treatment Needs
(CPITN) procedures (28). Briefly, for
each subject 10 index teeth (Tooth
Numbers: 11, 16, 17, 26, 27, 31, 36,
37, 46, 47) were examined and peri-
odontal pocket depth and/or CPITN
index scores recorded. Other peri-
odontal parameters, such as clinical
attachment loss, alveolar bone loss,
BOP and tooth mobility, were also
measured and saliva samples were col-
lected for laboratory analysis.
All subjects provided informed con-
sent and the study protocols were
reviewed and approved by the respec-
tive Institutional Review Boards at the
participating institutions. Information
on diagnosis of diabetes was obtained
through patient interview or examina-
tion of medical records as previously
described (22,27). Patients who smoked
at time of enrollment or in the past
were considered positive for smoking.
Disease definitions
In all three studies, patients with
moderate to severe periodontitis
were considered cases in case–control
comparisons. Owing to differences in
the methods used for examining
patients across studies, slightly differ-
ent criteria were used to define mod-
erate to severe periodontitis in each
population. In all cases, tooth loss
information was incorporated in the
case definition, as periodontitis is a
major cause of tooth loss (29) and
was expected to improve the accu-
racy.
For the discovery study (Caucasians
and African Americans) the following
criteria were used for identifying mod-
erate to severe periodontitis: (i) loss of
at least 10 teeth, i.e. ≤ 18 existing
teeth; or (ii) at least two interproximal
sites (not on same tooth) with ≥ 6 mm
clinical attachment loss and at least
one interproximal site with ≥ 5 mm
pocket depth; or (iii) at least two
interproximal sites with 4–5 mm clini-
cal attachment loss and no interproxi-
mal sites with clinical attachment loss
of ≥ 6 mm, and the percentage of sites
with pocket depth ≥ 4 mm should be
in the upper tertile of the study popu-
lation. These criteria were developed
based on the criteria described in an
earlier report (30).
A similar case definition was used in
the Hispanic validation study. The cri-
teria used for identifying moderate to
severe periodontitis were: (i) loss of at
least 10 teeth, i.e., ≤ 18 existing teeth,
or (ii) at least two interproximal sites
(not on same tooth) with ≥ 6 mm clini-
cal attachment loss and at least one
interproximal site with ≥ 5 mm pocket
depth, or (iii) at least two interproxi-
mal sites with ≥ 4 mm clinical attach-
ment loss (not on same tooth) or at
least two interproximal sites with
≥ 5 mm pocket depth (not on same
tooth), and the percentage of sites with
pocket depth ≥ 4 mm should be in the
upper tertile of the study population.
These criteria were modified from the
definitions proposed by a Center for
Disease Control/American Academy
of Periodontology working group
(31,32).
For the Asian validation study, the
subjects were classified into four cate-
gories based on severity of periodontal
disease using the following criteria: (i)
healthy: pocket depth < 3.5 mm; (ii)
mild: pocket depth 3.5–4 mm, clinical
attachment loss 1–2 mm, radiographic
bone loss ≤ 1
3 root length (optional),
tooth mobility not detectable; (iii)
moderate: 4 mm<pocket depth ≤ 6 mm,
clinical attachment loss 3–5 mm,
radiographic bone loss between one-
third and one-half root length
(optional), mild mobility; and (iv)
severe: pocket depth > 6 mm, clinical
attachment loss > 5 mm, radiographic
bone loss ≥ 12 root length (optional),
tooth mobility II–III degree. The
measurements used in the classifica-
tion were based on the worst affected
index tooth for each parameter.
Patients who had moderate to severe
periodontitis or lost at least 10 teeth
were considered cases while those
who were healthy with no periodonti-
tis were considered controls. Patients
with mild periodontitis were excluded
in the analysis because of potential
misclassification associated with the
partial mouth examination method
used in this study.
Genotyping
DNA was extracted from blood or sal-
iva samples according to standard pro-
tocols. Sections of the IL1B gene that
contain the SNPs of interest were
amplified by polymerase chain reaction
(PCR). Genotyping was performed
using the TaqMan 50 nuclease assay
(Applied Biosystems, Foster City, CA,
USA) or single base extension method
as previously described (21,33,34).
Briefly, for the Dental ARIC (DARIC)
study, DNA was extracted from blood
samples collected in EDTA-containing
tubes, amplified by PCR and
genotyped using the TaqMan nuclease
assay according to the manufacturer’s
instructions. For the Chilean
study, blood samples were collected
from study participants and DNA was
extracted from peripheral blood lym-
phocytes (27). DNA was amplified
using multiplex PCR that simulta-
neously amplify multiple DNA frag-
ments with the resulting PCR products
used for SNP genotyping by the single
base extension method with the
SNPstream instrument and chemistry
(Beckman Coulter, Brea, CA USA).
Allele calls were determined by the
SNPstream software and verified by a
laboratory technologist. For the
Shanghai study, saliva samples were
collected from study participants.
DNA was extracted and used for
genotyping with the TaqMan nucle-
ase assays and allele calls were
made by the TaqMan Genotyper
software and verified by a laboratory
scientist.
Four SNPs in the IL1B gene were
genotyped in all studies. These
included IL1B –511 (rs16944), IL1B –
1464 (rs1143623), IL1B –3737 (rs4848
306) and IL1B +3877 (rs1143633). All
genotyping assays were validated
before processing the study samples.
During the assay validation step,
negative controls (water), positive
controls of known genotypes (Coriell)
and a subset of study samples were
genotyped in duplicate. Genotyping
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performance was assessed by standard
methods. The genotyping error rates
were low (0.3–0.9%) and all SNPs
were found to be in Hardy–Weinberg
equilibrium with p values ranging from
0.13 to 0.91.
Statistical analysis
All analyses were performed using
SAS 9.2 (SAS Institute, Cary, NC,
USA). We commenced with descriptive
analyses of all variables of interest,
including the demographic informa-
tion, genetic markers and clinical data
for study. The associations between
individual SNPs, haplotypes and com-
posite genotypes and chronic peri-
odontal disease were determined using
chi-squared tests or Fisher’s exact
tests. Unadjusted and multivariable
logistic regressions adjusting for cova-
riates, such as age, smoking and diabe-
tes, were applied to estimate odds
ratios (OR) and 95% confidence inter-
vals (CI). Owing to the differences
between study populations, not all
analyses were adjusted for the same set
of covariates. For example, as no
patients with diabetes were enrolled in
the Chilean study, no adjustment for
diabetes was performed for analysis of
the Chilean population. For the dis-
covery study (USA) population,
patients were recruited from a rela-
tively narrow age range and age was
not adjusted in some analyses. Pooled
OR estimates of the three studies were
calculated using DerSimonian–Laird
random effects models (35), and
heterogeneity was assessed with the
Cochran Q test.
The incremental value of genotype
beyond known risk factors is evalu-
ated by assessing risk in non-smoking
individuals without diabetes. This
group, normally considered to be at
low risk for periodontal disease, is
stratified into genotype positive/geno-
type negative and significance of the
OR for the former relative to the lat-
ter is calculated. The incremental
value of genotype is reflected in the
proportion of people whose classifica-
tion changes from low to high risk
and in the magnitude and significance
of the elevated risk.
Results
Exploratory association of
functional IL1B gene variations with
moderate to severe chronic
periodontitis in a population cohort
consisting of both Caucasians and
African Americans
To identify genetic variants that con-
tribute to moderate to severe peri-
odontitis across multiple populations,
we first examined functional SNPs in
the IL1B gene in a population
cohort (DARIC) (23) that consists of
two ethnic groups, Caucasians and
African Americans (Table 1). The
SNPs involved were previously
shown to have allele-specific differ-
ences in transcription factor binding
and/or rate of transcription (20) and
were shown to be associated in a
haplotype context with inflammatory
biomarker levels (21). The functional
SNPs include three SNPs in the pro-
moter region (rs16944, rs1143623 and
rs4848306) and one SNP (rs1143633)
in intron 4 of the IL1B gene that
has been associated with biological
activity (36–38) but whose molecular
action has not been confirmed. The
three promoter SNPs produce four
predominant haplotypes (B1–B4)
(21), which in turn form 10
diplotypes (haplotype pairs). These
diplotypes can be further stratified
by the genotype of the intronic SNP
(rs1143633). Combinations of diplo-
types with or without stratification
by the intronic SNP produce differ-
ent composite genotype patterns. In
some analyses, patients with diabetes
were excluded due to differential
rates in Caucasians and African
Americans and its known influence
on periodontitis.
Individual SNPs, haplotypes and
diplotypes and a group of five
similar composite genotype patterns
(3, 15, 20, 22 and 29; Table 2) were
examined in this cohort. Two SNPs
(rs16944 and rs4848306), two haplo-
types (B1 and B4) and five diplo-
types (B1B2, B1B3, B2B4, B3B4 and
B4B4) were associated with either
increased or reduced risk for moder-
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ranging from 0.6 to 2.97, p values
ranging from < 0.0001 to 0.02,
adjusted for smoking and diabetes).
All five composite genotype patterns
were associated with moderate to
severe periodontitis in this cohort
consisting of two ethnicities (ORs
ranging from 1.48 to 1.87, p values
ranging from < 0.0001 to 0.004,
adjusted for smoking and diabetes;
Table 3). Pattern 3 demonstrated the
strongest association (OR = 1.87
[95% CI: 1.42–2.46]; p < 0.0001) with
the disease based on the OR and
was selected for validation in addi-
tional ethnic populations.
When the Caucasians and African
Americans from this cohort were
examined separately, the IL1B com-
posite genotype pattern 3 was associ-
ated with moderate to severe
periodontitis in each of these two eth-
nicities (OR = 1.44 and p = 0.04 for
non-diabetic Caucasians, OR = 4.28
and p = 0.0004 for non-diabetic Afri-
can Americans, adjusted for smoking)
in agreement with the findings for the
combined population.
Validation of the association
between an IL1B composite
genotype pattern and moderate to
severe chronic periodontitis in
Hispanic and Asian populations
To validate the association between
IL1B gene variation and moderate to
severe chronic periodontitis in His-
panics, patients selected from Santi-
ago, Chile were examined (27); these
included 166 patients with moderate
to severe periodontitis and 143 indi-
viduals with mild or no periodontitis.
IL1B genotype pattern 3 was signifi-
cantly associated with moderate to
severe periodontitis in this population
(OR = 1.95, p = 0.04, adjusted for
age and smoking).
To validate the association between
IL1B gene variation and moderate
and severe chronic periodontitis in
Asians, a population selected from
Shanghai, China was examined. All
study subjects were selected from a
pre-existing patient database in Shang-
hai where periodontal data were col-
lected for 10 index teeth for each
patient according to WHO’s CPITN
method (39). In this study, patients
with mild periodontitis were excluded
due to potential misclassification asso-
ciated with the partial mouth exami-
nation method used in the population
to assess periodontal disease status.
Compared to individuals without peri-
odontitis, patients with moderate to
severe periodontitis were more likely
to carry IL1B genotype pattern 3
(17% vs. 6%). The OR for moderate
to severe periodontitis for individuals
positive for IL1B genotype pattern 3
compared to individuals who were
negative for this genotype pattern
(OR = 3.27, p = 0.01, adjusted for
age, smoking and diabetes) showed a
significant association.
Meta-analysis
To assess the overall effect of IL1B
gene variation on periodontitis across
multiple ethnic populations, a meta-
analysis was conducted with data
obtained from the three studies above
which included four ethnicities. The
meta-analysis showed significant asso-
ciation between the IL1B composite
Table 2. IL1B alleles, haplotypes and composite genotype patterns
Allele
rs16944 rs1143623 rs4848306 rs1143633
IL1B (–511) IL1B (–1464) IL1B (–3737) IL1B (+3877)
1 C G C G
2 T C T A
Haplotype
rs16944 rs1143623 rs4848306
IL1B (–511) IL1B (–1464) IL1B (–3737)
B1 1 1 2
B2 2 2 1
B3 1 1 1
B4 2 1 1
Genotype
pattern Composite genotypes
3 (B1B1 and IL1B (+3877) = 1.1)/B2B3/B2B4/B3B3/B3B4/B4B4/(B1B4 and
IL1B (+3877) = 1.1)
15 B1B1/(B1B4 and IL1B (+3877) = 1.1)/B2B3/B2B4/B3B3/(B3B4 and IL1B
(+3877) = 1.1)/B4B4
20 B1B1/B2B3/B2B4/B3B3/(B3B4 and IL1B (+3877) = 2.*)/B4B4/(B1B4 and
IL1B (+3877) = 1.1)
22 B1B1/B2B3/B3B3/(B1B4 and IL1B (+3877) = 1.1)/(B2B4 and I
L1B (+3877) = 1.1)/(B3B4 and IL1B (+3877) = 1.1)/(B4B4 and IL1B
(+3877) = 1.1)
29 B3B3/B2B3/B2B4/B1B1/B3B4/B4B4/(B1B4 and IL1B (+3877) = 1.1)
Table 3. Association of IL1B genotype patterns with moderate to severe chronic periodon-






in control OR (95% CI)b p valueb
3 0.42 0.28 1.87 (1.42–2.46) < 0.0001
15 0.55 0.43 1.55 (1.20–2.00) 0.0009
20 0.53 0.43 1.54 (1.19–1.99) 0.001
22 0.53 0.42 1.48 (1.14–1.92) 0.004
29 0.57 0.44 1.66 (1.29–2.15) < 0.0001
aPatterns indicate pairs of IL1B promoter haplotypes comprised of IL1B rs16944;
rs1143623; and rs4848306. In some cases, IL1B rs1143633 further defines whether the
IL1B promoter haplotype pair is included in the pattern. Further details of definitions of
patterns appear in Table 2.
bAdjusted for smoking and diabetes.
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genotype pattern 3 and moderate to
severe periodontitis unadjusted for
risk factors (OR = 1.95 [95% CI:
1.54–2.46], p < 0.001; Table 4). In
fact, meta-analysis was significant in
all models that adjusted for risk fac-
tors. Heterogeneity was not detected
between these studies and a random
effects model was used to combine the
data.
IL1B gene variations have added
value to conventional risk factors in
predicting moderate to severe
periodontitis
Major conventional risk factors for
periodontitis include smoking and dia-
betes, and strong interactions between
the IL-1 gene variations and smoking
have been reported for periodontitis
(40–44). To address the question
whether the functional IL1B gene vari-
ations have added value to conven-
tional risk factors across ethnic
populations in predicting moderate to
severe periodontitis, the DARIC data
set (see Material and methods) was
used as it had data on all three risk fac-
tors. In this data set (n = 1100), the
frequency of moderate to severe peri-
odontitis cases was 53%. Among the
707 individuals who either smoked or
had diabetes or both, the rate of cases
was 61% vs. 40% for those with nei-
ther risk factor (OR = 2.4,
p < 0.0001). Among the remaining 393
individuals who had neither risk factor
and would otherwise be classified as
having low risk, 343 had data for IL-1
genotype, and 54% of the 110 patients
with IL1B genotype pattern 3 had
moderate to severe periodontitis versus
34% of those without this pattern
(OR = 2.3, p = 0.0005). Thus, 32% of
non-smoking patients without diabetes
can be classified as having higher risk
based on IL1B gene variations
(Table 5) [Corrections added on 17th
September 2014, after first online pub-
lication: errors were rectified in this
paragraph describing Table 5. The
conclusions arrived at from the data
remain unchanged.].
Discussion
We report that patterns of functional
SNPs in the regulatory region of the
IL1B gene were associated with moder-
ate to severe periodontitis in Cauca-
sians, African Americans, Hispanics
and Chinese. We believe that these
data add further support for the clini-
cal validity of IL-1 genetic variants as
a predictor of more severe or progres-
sive chronic periodontitis. In addition,
the study supports the concept that
functional genetic variants should be
inherently more informative than non-
functional genetic variants and may be
a key element of a common allele effect
in certain common diseases (45,46).
The clinical validity of previously
reported non-functional markers in
Table 4. Meta-analysis of IL1B genotype pattern 3 with the pooled ethnic populations
DARIC Chilean Shanghai Pooled
OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value OR (95% CI) p value
p for
Heterogeneitya
Model 1 1.86(1.42,2.45) < 0.001 1.97(1.12,3.45) 0.019 3.02(1.24,7.39) 0.015 1.95(1.54,2.46) < 0.001 0.596
Model 2 1.88(1.43,2.48) < 0.001 2.17(1.22,3.87) 0.009 3.42(1.36,8.63) 0.009 2.01(1.58,2.55) < 0.001 0.459
Model 3 1.91(1.45,2.52) < 0.001 1.95(1.03,3.69) 0.041 3.38(1.33,8.56) 0.011 1.99(1.56,2.55) < 0.001 0.516
Model 4 1.87(1.42,2.46) < 0.001 NAb NA 3.29(1.29,8.36) 0.012 2.06(1.35,3.15) 0.001 0.255
Model 5 1.90(1.43,2.50) < 0.001 NAb NA 3.27(1.28,8.35) 0.014 2.05(1.41,2.99) < 0.001 0.277
Model 1: unadjusted.
Model 2: adjusting for smoking.
Model 3: adjusting for smoking and age.
Model 4: adjusting for smoking and diabetes.
Model 5: adjusting for smoking, age and diabetes.
ap for Q-test for heterogeneity.
bPatients with diabetes were excluded in this study.
Table 5. The IL-1 genotype has added value to conventional risk factors, smoking and
diabetes, in predicting moderate to severe periodontitisa,*
Smoking or diabetesb IL-1 genotypec,d
(All subjects, n = 1100)
(Non-smoking and non-
diabetic: n = 343e)
Negative Positive Negative Positive
Control Count 237 277 154 51
% 60 39 66 46
Casef Count 156 430 79 59
% 40 61 34 54
aDARIC population.
bOR = 2.4, p < 0.0001.
cIL1B composite genotype pattern 3.
dOR = 2.3, p = 0.0005.
eOut of 393 individuals who were non-smoker and non-diabetic 343 had data for IL-1
genotype.
fModerate to severe periodontitis.
*[Corrections added on 17th September 2014, after first online publication: errors in Table
5 were rectified.].
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the IL1A (rs17561) and IL1B
(rs1143634) genes for severe periodon-
titis in Caucasians is supported by 19
studies to date and two meta-analyses
(9,10). However, the minor allele fre-
quencies of those markers vary greatly
among different ethnic populations,
with IL1A (+4845) reported at 26–
33% in Caucasians and 0.5–14% in
Asians and the minor allele frequen-
cies of IL1B (+3954) reported at 21–
29% in Caucasians and 1–7% in
Asians (47). The composite genotype
of the two was therefore uncommon
and uninformative in Asians (16). In
addition, contradicting findings have
been reported regarding the associa-
tion between these IL-1 markers and
periodontitis (10) or between these
markers and the production of IL-1
proteins (13,48); although in some
studies, the small sample size might
have contributed to negative or incon-
clusive findings. The IL-1 functional
patterns used in this study were found
commonly in all the populations stud-
ied, and as expected, the carriage rate
differed among the ethnic groups,
with for example 72% of African
Americans testing positive compared
to 27% of Caucasians and 11% of
Asians. Of Hispanics without peri-
odontitis 17% tested positive. The
influence of other genetic factors in
chronic periodontitis has not yet been
validated across multiple ethnicities,
but one may expect that the relative
contributions of different genetic fac-
tors may differ among ethnicities.
Similarly, although one may speculate
that some populations will have gene–
gene interactions that may mitigate
the influence of a functional genetic
variant we saw no evidence of any-
thing that differentially modified the
association between the disease and
the IL-1 variants by ethnicity.
The association of severe periodon-
titis with gene variants that increase
the expression of IL-1 protein levels
in gingival fluid is consistent with a
previously established critical role for
IL-1 in the pathogenesis of chronic
periodontitis. IL-1 protein level in
gingival fluid is one of the strongest
and most consistent predictors of
periodontitis severity and progression
(15,24,49–51). IL-1b is a downstream
regulator of osteoclastic bone resorp-
tion and matrix metalloproteinases 8,
9 and 13, which are implicated in the
tissue destruction characteristic of
periodontitis in humans (50,52–56).
Perhaps most importantly, in a pri-
mate model of periodontitis with an
aggressive bacterial induction of dis-
ease, recombinant soluble IL-1 recep-
tor type 1 protein that specifically
blocks IL-1 biological activity reduced
bone loss by 60% in spite of a contin-
uing bacterial challenge (57). The clin-
ical utility of IL-1 genetic variants in
periodontitis has recently been
demonstrated by showing that, in
dental patients with no history of
smoking or diabetes and not carrying
IL-1 gene variations, two preventive
dental cleanings annually had no ben-
efits beyond one annually in terms of
long-term tooth loss. Patients with
one or more of the risk factors, of
which the IL-1 genetic risk factor was
the most frequent, had significant
benefit from additional preventive
care (58).
This study has clear strengths,
including the use of multiple indepen-
dently derived populations from
diverse locations and backgrounds,
and the use of SNPs and haplotypes
with well-defined molecular function
that are associated with differential bi-
omarker expression at the clinical
level. In addition, the genotyping
for two of the three populations was
performed in a USA Clinical Labora-
tory Improvement Act-certified molec-
ular genetics laboratory, and samples
from the third population (Shanghai)
were genotyped in a laboratory in
China that had been validated against
the US laboratory providing valida-
tion of the genotyping results.
Although many genetic associations
with complex diseases are reported,
few are shown to have clinical validity
and clinical utility, which may be due
in part to the challenges of identifying
functional causative variants in non-
coding regulatory regions of the gen-
ome (46). The genetic patterns used in
this study include functional gene
variations in the IL1B promoter
region (20) that act in the haplotype
context to define significant differ-
ences in gingival crevicular fluid levels
of IL-1b and blood high-sensitivity C-
reactive protein levels (21).
Some limitations should also be
mentioned with respect to the study.
First, there are limited databases avail-
able for this type of study that include
adequate numbers of non-Caucasians
with appropriate disease characteris-
tics, and consent and availability of
DNA. Secondly, as the databases were
independently collected, the clinical
parameters differed among the data-
bases, which required that we establish
a broader definition of moderate to
severe generalized disease that could be
used across all of the populations.
Thirdly, essentially all accepted defini-
tions of periodontitis implicitly
describe currently measurable signs of
previous exposure to periodontitis, but
do not include missing teeth in the dis-
ease definition. Clinically, one may
extract six to eight teeth in a patient
with severe generalized periodontitis
and convert that patient to a clinical
definition of mild to moderate local-
ized disease. As genetics represents a
life-long exposure, we defined disease
criteria that automatically defaulted to
a severe disease classification if a cer-
tain number of teeth were missing. We
believe that this is a reasonable
approach to reduce misclassification, as
we are not aware of other approaches
to handle this issue and acknowledge
that this approach is a compromise.
Fourthly, not all SNPs included in the
disease-associated genotype patterns
have a well-established function. IL1B
(+3877) rs1143633 is included in the
patterns although its function has not
yet been validated. Previous studies,
and our own experience, suggest IL1B
(+3877) itself, or a locus in strong link-
age disequilibrium, is important in
differentiating multiple inflammatory
phenotypes in Asian populations
(59–61).
Chronic periodontitis is a complex
disease and several risk factors have
been validated as predictive of disease
severity and treatment response. Mul-
tiple studies have reported that com-
binations of IL-1 genotype and
smoking are additive predictors of
patient responses to periodontitis
therapy (40,41,43,44,62,63), as well as
complications following placement of
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dental implants (64,65). A small num-
ber of additional genetic variants have
been validated in multiple studies of
chronic periodontitis (66–70), and one
genome-wide association study has
implicated markers such as NIN,
NPY, WNT5A, NCR2, EMR1 and
10p15 (5). The field is currently con-
strained by the limited availability of
adequate databases to fully explore
and validate gene–gene interactions in
periodontitis. Those interactions may
be different in different ethnic popula-
tions and should be considered.
Conclusion
In conclusion, this study used func-
tional genetic variants in the promoter
region of the IL1B gene to validate
the influence of IL-1 genetic factors
on the severity of chronic periodonti-
tis across four different ethnicities.
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